Citadel Advisors
RDHL

Citadel Advisors’s Redhill Biopharma RDHL Stock Holding History

Citadel Advisors’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.2K Buy
65,321
+44,648
+216% +$41.2K ﹤0.01% 13078
2026
Q1 		$15.4K Buy
20,673
+5,196
+34% +$5.48K ﹤0.01% 12712
2025
Q4 		$15.9K Buy
+15,477
New +$20.8K ﹤0.01% 12391
2025
Q2 		– Sell
-21,512
Closed -$57.2K – 14632
2025
Q1 		$57.2K Buy
+21,512
New +$100K ﹤0.01% 12163
2024
Q3 		– Sell
-4,343
Closed -$40.2K – 15058
2024
Q2 		$40.2K Buy
+4,343
New +$48.2K ﹤0.01% 11988
2023
Q4 		– Sell
-2,231
Closed -$28.4K – 15075
2023
Q3 		$28.4K Buy
2,231
+1,602
+255% +$41.9K ﹤0.01% 12318
2023
Q2 		$19K Buy
+629
New +$36.3K ﹤0.01% 12768
2022
Q2 		– Sell
-58
Closed -$79.6K – 13886
2022
Q1 		$145K Sell
58
-45
-44% -$107K ﹤0.01% 11886
2021
Q4 		$265K Buy
103
+63
+158% +$252K ﹤0.01% 11203
2021
Q3 		$183K Buy
+40
New +$271K ﹤0.01% 12106
2020
Q4 		– Sell
-23
Closed -$207K – 11420
2020
Q3 		$240K Buy
+23
New +$189K ﹤0.01% 8519
2020
Q2 		– Sell
-19
Closed -$131K – 10378
2020
Q1 		$86K Buy
19
+7
+58% +$35K ﹤0.01% 8729
2019
Q4 		$75K Buy
+12
New +$76.7K ﹤0.01% 8654
2019
Q1 		– Sell
-18
Closed -$101K – 9760
2018
Q4 		$101K Buy
+18
New +$138K ﹤0.01% 8230
2018
Q2 		– Sell
-28
Closed -$145K – 9203
2018
Q1 		$145K Sell
28
-5
-15% -$28.8K ﹤0.01% 7560
2017
Q4 		$170K Buy
+33
New +$222K ﹤0.01% 7214

Other funds holding RDHL

YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $3.08B AUM 27.39% 1-Year Est. Return

Citadel Advisors's RDHL Position: Q2 2026 in Review

Citadel Advisors increased its Redhill Biopharma (RDHL) stake by 216% in Q2 2026, buying an estimated $41.2K and bringing the position to 65,321 shares worth $55.2K. The position accounts for ﹤0.01% of the portfolio, ranked #13078.

Citadel Advisors first reported a position in RDHL in Q4 2017 and has held it in 16 quarters since. The position peaked at $265K in Q4 2021. 14 funds tracked by Wall St. Rank hold RDHL as of Q2 2026.

  • Citadel Advisors held 65,321 shares of Redhill Biopharma worth $55.2K as of Q2 2026.
  • Citadel Advisors bought 44,648 Redhill Biopharma shares in Q2 2026, an estimated $41.2K.
  • Redhill Biopharma made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13078 holding.
  • Citadel Advisors first reported a position in Redhill Biopharma in Q4 2017 and has held it in 16 quarters since.
  • Citadel Advisors's Redhill Biopharma position peaked at $265K in Q4 2021.
  • 14 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.